Viral RNPs, mRNA Stability and Export
病毒 RNP、mRNA 稳定性和输出
基本信息
- 批准号:8307755
- 负责人:
- 金额:$ 18.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAntibodiesAntinuclear AntibodiesB-LymphocytesBindingBinding ProteinsBiological AssayCallithrixCancer EtiologyCebidaeCell LineCell NucleusCellsCollaborationsComplexElementsEpstein-Barr virus encoded RNA 1Epstein-Barr virus encoded RNA 2ExhibitsFunctional RNAGene ExpressionGrowthHerpesviridaeHomologous GeneHumanHuman Herpesvirus 4Human Herpesvirus 8Immunocompromised HostImmunofluorescence ImmunologicIn VitroIndividualInfectionInfectious MononucleosisLeftLengthLuciferasesLymphoid CellLymphomaLyticLytic PhaseMalignant NeoplasmsMessenger RNAMetabolismMicroRNAsMolecularMonkeysNMR SpectroscopyNuclearNuclear RNANucleotidesPathway interactionsPhenotypePoly(A)+ RNAPrimatesProteinsRNARNA DecayRNA SplicingReporterRepressionResistanceResolutionRibonucleoproteinsRoentgen RaysRoleSaimiriine Herpesvirus 2SiteSmall RNAStructureT-LymphocyteTailTestingTherapeuticTranslational RepressionTranslationsUntranslated RegionsViralViral PhysiologyVirusX-Ray Crystallographyantigen bindingbasecell transformationcombatdesigngammaherpesvirusgene functionin vivoinsightleukemia/lymphomamRNA ExportmRNA Stabilitymetaplastic cell transformationnovelpreventsarcomatranslation factorviral RNA
项目摘要
The roles of non-coding RNAs in lymphoid cells harboring three transforming herpesviruses are being
investigated. Epstein-Barr virus (EBV) infects and transforms humanB cells; it is the causative agent of
infectious mononucleosis and is associated with several human cancers. Herpesvirus saimiri (HVS) induces
fatal lymphomas and leukemias in New World monkeys and transforms human and monkey T lymphocytes
in culture, generating a mature; activated phenotype. Kaposi's sarcoma-associated herpesvirus (KSHV)
afflicts immunocompromised individuals and persists in a latent form until lytic activation. The two EBVencoded
EBERs, as well as >23 newly identified microRNAs, and the seven HVS-encoded HSURs are
expressed in virally transformed cells. Upon induction, KSHV produces PAN, a capped, polyadenylated RNA
that does not leave the nucleus. These viral RNAs are all small (from 21 nts to 1.1 kb), abundant, conserved,
and associate with host proteins to form RNPs. Studying their functions has,already contributed important
insights into host cell pathways perturbed during viral transformation or lytic growth.
Proposed aims will test the hypotheses that EBERs, HSURs and PAN manipulate cellular metabolism by
sequestering host proteins or microRNAs, or that the resulting RNPs perform a critical viral function. We
recently found that HSUR RNPs bind certain host microRNAs; interference with their regulatory roles in
transformed T cells will be examined. The possibility that EBERs likewise bind host microRNAs will be
tested. Our discovery that microRNAs in quiescent cells activate rather than repress translation will be
exploited to investigate the EBV-encoded microRNAs since many transformed B cells exist in a quiescent
state in the body. We showed that PAN RNA accumulates to very high nuclear levels in KSHV-reactivated
cells because an element (the ENE) near its 3' end engages the polyA tail to prevent RNA decay. Structural
studies of the ENE +/- oligoA, as well as complexed with polyA binding protein (PABPC1), will provide
mechanistic insights. Our observation that PAN RNA is involved in relocalization of host PABPC1 to the
nucleus, suggesting collaboration with the KSHV SOX protein in host mRNA shut off, will be investigated
携带三种转化疱疹病毒的淋巴细胞中非编码 RNA 的作用正在被研究
调查了。 Epstein-Barr 病毒 (EBV) 感染并转化人类 B 细胞;它是
传染性单核细胞增多症,与多种人类癌症有关。赛米尔疱疹病毒 (HVS) 诱导
新大陆猴致命性淋巴瘤和白血病,并转化人类和猴 T 淋巴细胞
在文化上,生成成熟;激活的表型。卡波西肉瘤相关疱疹病毒 (KSHV)
影响免疫功能低下的个体,并以潜伏形式持续存在,直至裂解激活。两个 EBVencoded
EBER 以及 > 23 个新识别的 microRNA 和 7 个 HVS 编码的 HSUR
在病毒转化的细胞中表达。诱导后,KSHV 产生 PAN,一种加帽的聚腺苷酸化 RNA
不会离开细胞核。这些病毒 RNA 都很小(从 21 nt 到 1.1 kb)、丰富、保守、
并与宿主蛋白结合形成 RNP。研究它们的功能已经做出了重要贡献
深入了解病毒转化或裂解生长过程中宿主细胞途径的扰动。
拟议的目标将测试 EBER、HSUR 和 PAN 通过以下方式操纵细胞代谢的假设:
隔离宿主蛋白或 microRNA,或者由此产生的 RNP 执行关键的病毒功能。我们
最近发现 HSUR RNP 结合某些宿主 microRNA;干扰其监管作用
将检查转化的 T 细胞。 EBER 同样结合宿主 microRNA 的可能性是
已测试。我们发现静止细胞中的 microRNA 会激活而不是抑制翻译
由于许多转化的 B 细胞存在于静止状态,因此可用于研究 EBV 编码的 microRNA
体内的状态。我们发现 PAN RNA 在 KSHV 重新激活的细胞核中积累到非常高的水平
细胞,因为其 3' 端附近的一个元件(ENE)与 PolyA 尾部接合以防止 RNA 衰变。结构性
ENE +/- 寡A以及与多聚A结合蛋白(PABPC1)复合的研究将提供
机制的见解。我们观察到 PAN RNA 参与宿主 PABPC1 重新定位到
细胞核,表明与 KSHV SOX 蛋白在宿主 mRNA 关闭中的合作,将进行研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOAN A. STEITZ其他文献
JOAN A. STEITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOAN A. STEITZ', 18)}}的其他基金
Viral Noncoding RNAs and Cell Transformation
病毒非编码 RNA 和细胞转化
- 批准号:
10364830 - 财政年份:2022
- 资助金额:
$ 18.78万 - 项目类别:
Viral Noncoding RNAs and Cell Transformation
病毒非编码 RNA 和细胞转化
- 批准号:
10553131 - 财政年份:2022
- 资助金额:
$ 18.78万 - 项目类别:
SMALL NUCLEAR RNAS ENCODED BY HERPESVIRUS SAIMIRI
疱疹病毒 SAIMIRI 编码的小核 RNA
- 批准号:
7349566 - 财政年份:2006
- 资助金额:
$ 18.78万 - 项目类别:
VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATION
病毒小 RNPS——在细胞转化中的作用
- 批准号:
6268827 - 财政年份:1998
- 资助金额:
$ 18.78万 - 项目类别:
VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATION
病毒小 RNPS——在细胞转化中的作用
- 批准号:
6236232 - 财政年份:1997
- 资助金额:
$ 18.78万 - 项目类别:
相似海外基金
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别: